Featured Research

from universities, journals, and other organizations

Beta-blockers May Help Broader Group Of Patients With Heart Problems

Date:
March 17, 2005
Source:
University Of Southern California
Summary:
Beta-blockers, medications that block the action of certain hormones on the heart, can benefit patients with certain serious heart problems such as diastolic heart failure, according to cardiologists at the Keck School of Medicine of the University of Southern California and Loma Linda University Medical Center.

ORLANDO, Fla., March 7, 2005 - Beta-blockers, medications that block the action of certain hormones on the heart, can benefit patients with certain serious heart problems such as diastolic heart failure, according to cardiologists at the Keck School of Medicine of the University of Southern California and Loma Linda University Medical Center.

Researchers presented two reports on the use of beta-blockers in patients with chronic severe mitral regurgitation, or MR, and congestive heart failure, CHF, at the American College of Cardiology's 54th Annual Scientific Session on March 7. These patients had a normal ejection fraction, a measure of how well the heart pumps out blood.

"Our findings are encouraging because there are no data on the survival benefit of medical therapy in CHF or severe MR patients with normal ejection fraction. CHF with normal ejection fraction, popularly referred to as diastolic heart failure, makes up nearly 50 percent of all CHF patients-and these patients have very similar mortality and morbidity as those with reduced ejection fraction," says Padmini Varadarajan, M.D., advanced cardiac imaging fellow in the Department of Cardiovascular Medicine at the Keck School of Medicine and the study's lead author.

In their first presentation, researchers showed that using beta-blockers as part of therapy significantly reduced risk of death for patients with chronic severe mitral regurgitation with normal ejection fraction.

The mitral valve separates the heart's left atrium from the left ventricle. With every heartbeat, oxygen-rich blood moves from the left atrium, a holding chamber, to the left ventricle, which squeezes or ejects the blood out to the rest of the body.

When the mitral valve does not close well, blood can flow from the ventricle back into the atrium-a condition called mitral regurgitation. That means blood flow to the rest of the body decreases, and the heart may have to work extra hard to compensate.

Doctors can see how well the left ventricle works by measuring the ejection fraction, which is the percentage of blood squeezed out of the ventricle with each heartbeat. An ejection fraction of 50 percent means the ventricle spurts out half its volume each time it contracts.

Healthy ejection fractions are 50 percent or higher; lower ejection fractions can mean heart disease. But patients may have normal ejection fractions and still have serious heart problems such as severe mitral regurgitation.

In the study, 32 percent of 869 participating mitral regurgitation patients were on a beta-blocker. Beta-blockers reduce the heart rate and the force of muscle contraction, thereby reducing oxygen demand on heart muscle.

The researchers found that beta-blockers increased patients' survival, independent of patients' age, gender, or whether they had coronary artery disease, diabetes, high blood pressure or valve surgery.

In a related poster, researchers showed the drugs' benefits to patients with diastolic heart failure-those with congestive heart failure, or CHF, who have normal ejection fraction.

Researchers studied 2,246 patients with CHF; 1,079 of them had normal ejection fractions. The patients were on a variety of CHF therapy regimens, which might include aspirin, diuretics, digoxin, ACE inhibitors and beta-blockers.

Beta-blockers were once thought risky for heart-failure patients. But the investigators found that after five years, 65 percent of patients treated with beta-blockers were alive, compared to 50 percent of those who received no beta-blockers. Beta-blocker therapy still showed a strong survival benefit after researchers adjusted for patients' age, gender, hypertension, diabetes and coronary artery disease.

Ramdas G. Pai, M.D., professor of clinical cardiovascular medicine at the Keck School and the study's senior author, explained that catecholamines-the hormones released in the body in stress situations such as heart failure and mitral regurgitation-are toxic to the heart muscle. Beta-blockers keep catecholamines from acting.

"For the first time, our large observational studies show that beta-blockers may have large benefit in CHF and severe MR patients with normal ejection fraction. However these findings need to be substantiated further by randomized clinical trials," she says. She and her colleagues are planning further study on the drugs.


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "Beta-blockers May Help Broader Group Of Patients With Heart Problems." ScienceDaily. ScienceDaily, 17 March 2005. <www.sciencedaily.com/releases/2005/03/050310104739.htm>.
University Of Southern California. (2005, March 17). Beta-blockers May Help Broader Group Of Patients With Heart Problems. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2005/03/050310104739.htm
University Of Southern California. "Beta-blockers May Help Broader Group Of Patients With Heart Problems." ScienceDaily. www.sciencedaily.com/releases/2005/03/050310104739.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins